Not yet recruiting
Clinical Trial of SEEG for Drug-resistant Epilepsy
NCT07923058· Beijing Pins Medical Co., Ltd· Source
Contact: Junming Zhu
Not yet recruiting
AI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis
NCT07782294· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Yuehua Han
Not yet recruiting
Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis
NCT07530367· Phase 3· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Xibei Chen
Recruiting
AI-Optimized Single-Feature Recognition Model for Heart Failure
NCT07667452· Vivalink· Source
Contact: Bing Yang
Not yet recruiting
Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT07669194· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Jiefeng Tong
Recruiting
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
NCT07516288· Phase 1· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Jiamin Li, Dr
Recruiting
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
NCT07444060· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Yan Chen
Not yet recruiting
Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock
NCT07380659· Phase 1· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Xinyang Hu
Recruiting
Epidural Spinal Cord Stimulation for Restoring Walking in Spinal Cord Injury
NCT07306052· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Junming Zhu, Chief Physician
Recruiting
Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder
NCT07466277· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Zhiying MD Wu
Recruiting
Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)
NCT07244328· Early phase 1· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Yang, Doctor
Active, not recruiting
ClinicAL outComes of IntraVascular Lithotripsy Combined With Conventional Lesion Preparation in Patients With Moderate to Severe Coronary Artery Calcification
NCT07340294· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Recruiting
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
NCT07385131· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Yan Chen
Not yet recruiting
A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC
NCT07086326· Phase 2· Yang Fan, MD· Source
Recruiting
Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
NCT07061535· Phase 2· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Yang Xia, MD, PhD
Recruiting
Epidural Electrical Stimulation in Spinal Cord Injury (T11-L3)
NCT07207798· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Zhoule Zhu
Recruiting
Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction
NCT06742125· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Chi Liu
Recruiting
Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma
NCT07078500· Phase 2· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Hui Liu
Recruiting
Effect of Video Viewing on Intravitreal Injection Experience
NCT07002372· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Fang Zheng
Recruiting
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
NCT06902896· Phase 1/2· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Xinyang Hu
Recruiting
Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial
NCT06863532· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Wenheng Zeng, Doctor
Recruiting
Epidural Electrical Stimulation in Spinal Cord Injury
NCT07105878· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Junming Zhu, Chief Physician
Enrolling by invitation
Evaluation of Endoscopic Treatment Effect Based on HVPG
NCT06863519· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Recruiting
Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy
NCT05824520· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Jun Jiang, MD
Recruiting
Assessment of CT-FFR in Patients With CCS: A Prospective Multicenter Cohort Study
NCT07659119· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Jun Jiang, MD
Recruiting
Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer
NCT06523673· Phase 3· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Fuming Qiu, PhD
Recruiting
Rectosigmoid Lesion Excision vs. Resection: A Non-Inferiority Randomized Comparison in Advanced Ovarian Cancer
NCT07616310· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Jing Fei
Not yet recruiting
Effectiveness of Ketogenic Diet in MELAS Syndrome
NCT06013397· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Yao Ding, doctor
Recruiting
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas
NCT05830123· Phase 2· Hansoh BioMedical R&D Company· Source
Contact: Wei Guo, MD
Recruiting
Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
NCT05731726· Phase 2· Zhejiang University· Source
Contact: Jinjie He, Doctor
Not yet recruiting
Prediction of Development and Rupture Risk for Intracranial Unruptured Aneurysms
NCT05576727· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Gao Chen
Active, not recruiting
A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
NCT05488314· Phase 1/2· Janssen Research & Development, LLC· Source
Active, not recruiting
Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC(neoSCORE Ⅱ)
NCT05429463· Phase 3· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Recruiting
The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma
NCT05323929· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Yuqi Wang, Doctor
Active, not recruiting
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
NCT04988295· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT04487080· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT04454177· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Xianbao Liu, MD, PhD
Recruiting
Chinese Psoriasis Real World Evidence Research
NCT04465838· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source
Contact: Xiao-Yong Man, MD